Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer

被引:21
|
作者
Grbcic, Petra [1 ]
Sedic, Mirela [1 ]
机构
[1] Univ Rijeka, Dept Biotechnol, Radmile Matejcic 2, Rijeka 51000, Croatia
来源
MOLECULES | 2020年 / 25卷 / 10期
关键词
colon cancer; chemoresistance; sphingosine; 1-phosphate; sphingolipid metabolism; sphingosine kinases; RETINOIC ACID ATRA; COLORECTAL-CANCER; KINASE; SPHINGOSINE-1-PHOSPHATE RECEPTORS; CELL-PROLIFERATION; P-GLYCOPROTEIN; EXPRESSION; MODULATION; FTY720; CYCLOOXYGENASE-2;
D O I
10.3390/molecules25102436
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal carcinoma (CRC) is the leading cause of cancer-related deaths worldwide. Despite advances in prevention and treatment modalities for CRC, rapidly developing resistance to chemotherapy limits its effectiveness. For that reason, it is important to better understand the mechanisms that undergird the process of chemoresistance to enable design of novel anticancer agents specifically targeting malignant properties of cancer cells. Over recent decades, bioactive sphingolipid species have come under the spotlight for their recognized role in cancer development and progression, and the evidence has surfaced to support their role as regulators of anti-cancer drug resistance. Colon cancer is characterized by a shift in sphingolipid balance that favors the production and accumulation of oncogenic species such as sphingosine 1-phosphate (S1P). S1P is known to govern the processes that facilitate cancer cell growth and progression including proliferation, survival, migration, invasion and inflammation. In this review paper, we will give a comprehensive overview of current literature findings on the molecular mechanisms by which S1P turnover, transport and signaling via receptor-dependent and independent pathways shape colon cancer cell behavior and influence treatment outcome in colon cancer. Combining available modulators of S1P metabolism and signaling with standard chemotherapy drugs could provide a rational approach to achieve enhanced therapeutic response, diminish chemoresistance development and improve the survival outcome in CRC patients.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Sphingosine 1-phosphate metabolism and insulin signaling
    Wigger, Dominik
    Schumacher, Fabian
    Schneider-Schaulies, Sibylle
    Kleuser, Burkhard
    CELLULAR SIGNALLING, 2021, 82
  • [2] Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism
    Kwong E.K.
    Li X.
    Hylemon P.B.
    Zhou H.
    Current Pharmacology Reports, 2017, 3 (4) : 176 - 183
  • [3] Sphingosine 1-phosphate signaling
    Hla, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 76 - 76
  • [4] The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators
    Soliven, Betty
    Miron, Veronique
    Chun, Jerold
    NEUROLOGY, 2011, 76 (08) : S9 - S14
  • [5] Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function
    Serra, Montserrat
    Saba, Julie D.
    ADVANCES IN ENZYME REGULATION, VOL 50, 2010, 50 : 349 - 362
  • [6] Sphingosine 1-Phosphate Receptor Signaling
    Rosen, Hugh
    Gonzalez-Cabrera, Pedro J.
    Sanna, M. Germana
    Brown, Steven
    ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 : 743 - 768
  • [7] Sphingosine 1-phosphate and cancer
    Pyne, Nigel J.
    Pyne, Susan
    NATURE REVIEWS CANCER, 2010, 10 (07) : 489 - 503
  • [8] Sphingosine 1-phosphate and cancer
    Nigel J. Pyne
    Susan Pyne
    Nature Reviews Cancer, 2010, 10 : 489 - 503
  • [9] The role of sphingosine 1-phosphate/sphingosine 1-phosphate receptor signaling in the pathogenesis of rheumatoid arthritis
    Kitano, M.
    Tam, Y. Y.
    Sekiguchi, M.
    Kuroda, M.
    Kuno, H.
    Kuroiwa, T.
    Hashimoto, N.
    Matsui, K.
    Iwasaki, T.
    Saba, J.
    Hla, T.
    Sano, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 132 - 132
  • [10] Lysophosphatidate Promotes Sphingosine 1-Phosphate Metabolism and Signaling: Implications for Breast Cancer and Doxorubicin Resistance
    Venkatraman, Ganesh
    Tang, Xiaoyun
    Du, Guangwei
    Parisentti, Amadeo M.
    Hemmings, Denise G.
    Brindley, David N.
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2021, 79 (03) : 531 - 545